BG00010 (Neublastin)
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for BG00010 (Neublastin), covering 2014-10-28 to 2015-09-10. Get the full timeline:
Most recent: Clinical Trial Update: BG00010 (Neublastin) Phase 2 Multiple Dose Adaptive Design in Participants With Painful Lumbar Radiculopathy [Phase 2]